Today: 2 May 2026
ASX 200 drops on bank selloff as BlueScope jumps on $13.15 bln bid; inflation data next
6 January 2026
2 mins read

ASX 200 drops on bank selloff as BlueScope jumps on $13.15 bln bid; inflation data next

Sydney, January 6, 2026, 20:58 AEDT — Market closed

  • S&P/ASX 200 fell 0.52% to 8,682.8, its weakest session in three weeks. 
  • Big banks slid 2%–3% as investors rebalanced and rate bets firmed ahead of inflation data due Wednesday. 
  • BlueScope jumped 21% after SGH and Steel Dynamics pitched A$30 a share in cash. 

Australian shares logged their weakest session in three weeks on Tuesday as heavy losses in the big banks outweighed a rally in miners, leaving the benchmark S&P/ASX 200 down 0.52% at 8,682.8. 

The near-term focus is inflation. The Australian Bureau of Statistics is due to publish its November monthly consumer price index (CPI) on Wednesday, January 7, with economists looking for the annual pace to ease to about 3.7% from 3.8%. 

That print matters because it feeds straight into expectations for the Reserve Bank of Australia’s next move. Markets have recently shifted to price a roughly one-in-three chance of a rate hike as soon as February, after the central bank’s more hawkish messaging on inflation. 

Bank stocks took the brunt of the selling, with Commonwealth Bank of Australia dropping about 3% and the other major lenders losing roughly 2% or more. “Looking at the market map, the banks are the main issue and there are a number of factors at play,” Moomoo market strategist Michael McCarthy told AAP, pointing to valuation concerns and early-year portfolio rebalancing. AAP News

One strategist warned the rate narrative could splinter performance across sectors. “If the market starts pricing in rate increases, the ASX is likely to see more differentiated performance across sectors rather than a broad rally,” Marc Jocum, senior product and investment strategist at Global X ETFs Australia, said. Indo Premier

Miners pushed the other way, with the sector finishing at a record close on stronger commodity prices, while copper-linked names rose after the metal hit a fresh high above $US13,000 a tonne. Iron ore majors BHP, Rio Tinto and Fortescue all climbed about 1.5% or more, AAP reported. 

BlueScope Steel was the day’s standout, closing up 21% at A$29.54 after it disclosed a non-binding indicative offer — a preliminary approach that is not yet firm — from Kerry Stokes-controlled SGH and U.S.-based Steel Dynamics valuing the company at A$13.15 billion (US$8.78 billion). Steel Dynamics CEO and chair Mark Millett said the deal would be “highly complementary” to its existing operations. Reuters+1

Deal talk brought its own sceptics. “I see the SGH-led proposal as opportunistic but potentially value-unlocking for shareholders, albeit highly conditional and execution-heavy,” said Mark Gardner, CEO of MPC Markets, while Opal Capital Management CIO Omkar Joshi said bidders would likely need to lift the price before the offer could be accepted. Reuters

Away from M&A, Silex Systems sank about a third after a key licensee missed out on a U.S. government funding program, while the Australian dollar held near 14-month highs around 67.27 U.S. cents, AAP said. 

The risk is that Wednesday’s CPI print runs hotter than forecast, pushing up the odds of a February hike and extending the pressure on rate-sensitive stocks — companies whose earnings and valuations are more exposed to interest-rate shifts, including banks and retailers.

Next up is the November CPI release on Wednesday, January 7, followed by December labour force data due Thursday, January 22, and the RBA’s next policy decision scheduled for Tuesday, February 3. 

Stock Market Today

  • Novo Nordisk Shares Rebound Amid Valuation Debate
    May 2, 2026, 5:29 AM EDT. Novo Nordisk (NYSE:NVO) shares rose 14.9% over the past month, recovering from weaker longer-term returns. The stock closed at $42.22, below an implied analyst fair value near $47.71 and a widely cited fair value estimate of $95, suggesting potential undervaluation. Management narrowed 2025 guidance to 8-11% sales growth and 4-7% operating profit growth, citing intensified competition and pricing pressures in diabetes and obesity markets. The valuation rebound may reflect a short-term recovery rather than a sustained trend, with risks including further price pressures and faster adoption of competitor treatments. Investors are advised to weigh both risks and rewards and consider broader sector opportunities before making decisions.

Latest article

Beyond ChatGPT And Nvidia: 3 Technologies Wall Street May Have To Reprice Before 2026 Ends

Beyond ChatGPT And Nvidia: 3 Technologies Wall Street May Have To Reprice Before 2026 Ends

2 May 2026
The S&P 500 and Nasdaq closed at record highs Friday as Alphabet, Amazon, Meta, and Microsoft projected 2026 AI spending above $700 billion. Meta shares dropped nearly 10% after raising its capital-spending outlook, while Alphabet rose on strong Google Cloud revenue. Meta acquired Assured Robot Intelligence, expanding into robotics AI. Google began selling its AI chips directly to customers, challenging Nvidia.
Forget Big Tech: Data Storage Stocks Are Becoming AI’s Quiet Market Dark Horse

Forget Big Tech: Data Storage Stocks Are Becoming AI’s Quiet Market Dark Horse

2 May 2026
Seagate shares rose 7.9% and Sandisk jumped 8.3% Friday, while Western Digital slipped 0.6%. Sandisk reported Q3 revenue up 251% to $5.95 billion and signed $42 billion in long-term supply deals. Western Digital’s Q3 revenue climbed 45% to $3.34 billion, topping analyst estimates. Seagate forecast Q4 revenue of $3.45 billion, citing AI-driven demand.
Vodafone stock rises above 100p as buyback disclosure sharpens focus on Feb 5 update
Previous Story

Vodafone stock rises above 100p as buyback disclosure sharpens focus on Feb 5 update

Marks & Spencer (MKS.L) shares fall as Jan 8 Christmas trading update looms
Next Story

Marks & Spencer (MKS.L) shares fall as Jan 8 Christmas trading update looms

Go toTop